RAPAFLO® (silodosin)
PATIENT ASSISTANCE PROGRAM

The RAPAFLO® Patient Assistance Program (PAP) helps uninsured patients gain access to RAPAFLO®. Eligibility for PAP is determined based on various medical and financial qualifications.

ELIGIBILITY CRITERIA

In order to qualify for PAP a patient must:

  • Be a U.S. resident
  • Have an FDA-approved diagnosis
  • Have a household income that is less than 200%
    of the Federal Poverty Limit
  • Have no prescription drug coverage

For more information about the RAPAFLO®
Patient Assistance Program, call 1-800-851-0758




DOWNLOAD APPLICATION